Literature DB >> 33465107

Blocking IL-10 signaling with soluble IL-10 receptor restores in vitro specific lymphoproliferative response in dogs with leishmaniasis caused by Leishmania infantum.

Catiule de Oliveira Santos1, Sidnei Ferro Costa2, Fabiana Santana Souza1, Jessica Mariane Ferreira Mendes1, Cristiane Garboggini Melo de Pinheiro1, Diogo Rodrigo de Magalhães Moreira1, Luciano Kalabric Silva1, Valeria Marçal Felix de Lima2, Geraldo Gileno de Sá Oliveira1.   

Abstract

rIL-10 plays a major role in restricting exaggerated inflammatory and immune responses, thus preventing tissue damage. However, the restriction of inflammatory and immune responses by IL-10 can also favor the development and/or persistence of chronic infections or neoplasms. Dogs that succumb to canine leishmaniasis (CanL) caused by L. infantum develop exhaustion of T lymphocytes and are unable to mount appropriate cellular immune responses to control the infection. These animals fail to mount specific lymphoproliferative responses and produce interferon gamma and TNF-alpha that would activate macrophages and promote destruction of intracellular parasites. Blocking IL-10 signaling may contribute to the treatment of CanL. In order to obtain a tool for this blockage, the present work endeavored to identify the canine casIL-10R1 amino acid sequence, generate a recombinant baculovirus chromosome encoding this molecule, which was expressed in insect cells and subsequently purified to obtain rcasIL-10R1. In addition, rcasIL-10R1 was able to bind to homologous IL-10 and block IL-10 signaling pathway, as well as to promote lymphoproliferation in dogs with leishmaniasis caused by L. infantum.

Entities:  

Year:  2021        PMID: 33465107      PMCID: PMC7815104          DOI: 10.1371/journal.pone.0239171

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  63 in total

Review 1.  Methods of endotoxin removal from biological preparations: a review.

Authors:  Pérola O Magalhães; André M Lopes; Priscila G Mazzola; Carlota Rangel-Yagui; Thereza C V Penna; Adalberto Pessoa
Journal:  J Pharm Pharm Sci       Date:  2007       Impact factor: 2.327

2.  Blocking of interleukin-10 receptor--a novel approach to stimulate T-helper cell type 1 responses to hepatitis C virus.

Authors:  Eirini I Rigopoulou; William G H Abbott; Philip Haigh; Nikolai V Naoumov
Journal:  Clin Immunol       Date:  2005-10       Impact factor: 3.969

3.  Improved dendritic cell-based immunization against hepatitis C virus using peptide inhibitors of interleukin 10.

Authors:  Nancy Díaz-Valdés; Lorea Manterola; Virginia Belsúe; José I Riezu-Boj; Esther Larrea; Itziar Echeverria; Diana Llópiz; Jacinto López-Sagaseta; Hervé Lerat; Jean-Michel Pawlotsky; Jesús Prieto; Juan J Lasarte; Francisco Borrás-Cuesta; Pablo Sarobe
Journal:  Hepatology       Date:  2010-12-13       Impact factor: 17.425

4.  Orf virus-encoded interleukin-10 stimulates the proliferation of murine mast cells and inhibits cytokine synthesis in murine peritoneal macrophages.

Authors:  Wendy Imlach; Catherine A McCaughan; Andrew A Mercer; David Haig; Stephen B Fleming
Journal:  J Gen Virol       Date:  2002-05       Impact factor: 3.891

5.  Inhibitory and stimulatory effects of IL-10 on human CD8+ T cells.

Authors:  H Groux; M Bigler; J E de Vries; M G Roncarolo
Journal:  J Immunol       Date:  1998-04-01       Impact factor: 5.422

6.  Cloning and characterization of recombinant rhesus macaque IL-10/Fc(ala-ala) fusion protein: a potential adjunct for tolerance induction strategies.

Authors:  C Asiedu; V Guarcello; L Deckard; U Jargal; B Gansuvd; E P Acosta; J M Thomas
Journal:  Cytokine       Date:  2007-11-05       Impact factor: 3.861

Review 7.  Canine leishmaniosis - new concepts and insights on an expanding zoonosis: part one.

Authors:  Gad Baneth; Alexander F Koutinas; Laia Solano-Gallego; Patrick Bourdeau; Lluis Ferrer
Journal:  Trends Parasitol       Date:  2008-05-29

8.  Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes.

Authors:  F Willems; A Marchant; J P Delville; C Gérard; A Delvaux; T Velu; M de Boer; M Goldman
Journal:  Eur J Immunol       Date:  1994-04       Impact factor: 5.532

9.  Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines.

Authors:  P R Burd; H W Rogers; J R Gordon; C A Martin; S Jayaraman; S D Wilson; A M Dvorak; S J Galli; M E Dorf
Journal:  J Exp Med       Date:  1989-07-01       Impact factor: 14.307

Review 10.  Biology and therapeutic potential of interleukin-10.

Authors:  Margarida Saraiva; Paulo Vieira; Anne O'Garra
Journal:  J Exp Med       Date:  2020-01-06       Impact factor: 14.307

View more
  1 in total

1.  Nasal Immunization With Small Molecule Mast Cell Activators Enhance Immunity to Co-Administered Subunit Immunogens.

Authors:  Brandi T Johnson-Weaver; Hae Woong Choi; Hang Yang; Josh A Granek; Cliburn Chan; Soman N Abraham; Herman F Staats
Journal:  Front Immunol       Date:  2021-09-10       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.